A 10-year-old girl who has been battling leukemia for more than four years has become the first person in Taiwan to be successfully treated with a new form of immunotherapy, doctors at National Taiwan University Hospital (NTUH) said yesterday.
The child, identified only as Ting-ting (亭亭), was diagnosed with pediatric B-cell acute lymphoblastic leukemia at the age of six and was initially receiving targeted chemotherapy, her doctors told a news conference.
When her leukemia recurred last year, doctors recommended the CD19 chimeric antigen receptor (CAR) T-cell therapy — a immunotherapy treatment that was introduced in the past decade and had never previously been used successfully to treat a person with leukemia in Taiwan.
Photo: Chiu Chih-jou, Taipei Times
After an infusion of CD19 CAR T-cells in April, Ting-ting’s cancer went into complete remission, the doctors said, adding that she was recently able to spend her 10th birthday at home with her family.
CAR T therapies became prominent in 2012, when they were successfully used in a clinical trial to treat Emily Whitehead, a six-year-old American girl who had been diagnosed with leukemia.
In such therapies, immune cells called T-cells are taken from a patient’s blood and modified by adding a gene for a CAR, which helps them attach to the specific cancer cell antigen. They are then put back in the patient.
Ting-ting’s mother recalled the difficulty she had in explaining the cancer diagnosis to such a young child, telling the news conference that she eventually told her daughter it was “like having a cold” and would get better if she took her medicine.
She thanked her daughter’s medical team for discussing with her the option of CAR T-cell therapy, which she said allowed them to begin the treatment as soon as Ting-ting’s cancer recurred.
Cancer is the second-leading cause of death among children in Taiwan and leukemia accounts for a significant proportion, said Lee Wang-tso (李旺祚), director of NTUH’s Department of Pediatrics.
In the past, the options for treating pediatric leukemia have been limited mainly to chemotherapy, which can cause adverse reactions, and bone marrow transplants, which are difficult to arrange and sometimes require the patient to take immunosuppressant drugs indefinitely, Lee said.
Jou Shiann-tang (周獻堂), a doctor in the hospital’s Department of Hematology and Oncology, said that about 500 new pediatric leukemia cases are diagnosed in Taiwan each year.
About one-quarter of them are acute lymphoblastic leukemia and about 15 percent of such patients have adverse reactions to treatment or the cancer recurs, Jou said.
Ting-ting’s parents said that the CD19 CAR T-cell therapy has the potential to help other children.
However, the treatment is not covered by the National Health Insurance, which meant that they had to sell their home to pay the NT$10 million (US$334,571) it cost.
The National Health Insurance Administration is reviewing whether to cover such treatments in the future, the hospital said.
Thirty-five earthquakes have exceeded 5.5 on the Richter scale so far this year, the most in 14 years, the Central Weather Administration (CWA) said on Facebook on Thursday. A large earthquake in Hualien County on April 3 released five times as much the energy as the 921 Earthquake on Sept. 21, 1999, the agency said in its latest earthquake report for this year. Hualien County has had the most national earthquake alerts so far this year at 64, with Yilan County second with 23 and Changhua County third with nine, the agency said. The April 3 earthquake was what caused the increase in
INTIMIDATION: In addition to the likely military drills near Taiwan, China has also been waging a disinformation campaign to sow division between Taiwan and the US Beijing is poised to encircle Taiwan proper in military exercise “Joint Sword-2024C,” starting today or tomorrow, as President William Lai (賴清德) returns from his visit to diplomatic allies in the Pacific, a national security official said yesterday. Commenting on condition of anonymity, the official said that multiple intelligence sources showed that China is “highly likely” to launch new drills around Taiwan. Although the drills’ scale is unknown, there is little doubt that they are part of the military activities China initiated before Lai’s departure, they said. Beijing at the same time is conducting information warfare by fanning skepticism of the US and
Chinese President Xi Jinping (習近平) is unlikely to attempt an invasion of Taiwan during US president-elect Donald Trump’s time in office, Taiwanese and foreign academics said on Friday. Trump is set to begin his second term early next year. Xi’s ambition to establish China as a “true world power” has intensified over the years, but he would not initiate an invasion of Taiwan “in the near future,” as his top priority is to maintain the regime and his power, not unification, Tokyo Woman’s Christian University distinguished visiting professor and contemporary Chinese politics expert Akio Takahara said. Takahara made the comment at a
DEFENSE: This month’s shipment of 38 modern M1A2T tanks would begin to replace the US-made M60A3 and indigenous CM11 tanks, whose designs date to the 1980s The M1A2T tanks that Taiwan expects to take delivery of later this month are to spark a “qualitative leap” in the operational capabilities of the nation’s armored forces, a retired general told the Liberty Times (sister paper of the Taipei Times) in an interview published yesterday. On Tuesday, the army in a statement said it anticipates receiving the first batch of 38 M1A2T Abrams main battle tanks from the US, out of 108 tanks ordered, in the coming weeks. The M1 Abrams main battle tank is a generation ahead of the Taiwanese army’s US-made M60A3 and indigenously developed CM11 tanks, which have
RSS